Sana Biotechnology reclassifies director to rebalance board classes

Filed April 24, 2026 · Period ending April 22, 2026 · ~1 min read

Key Changes

• low

  Dr. Steven D. Harr moved from Class I to Class III director on April 22, 2026, changing his term expiration from 2028 to 2027. The technical reclassification rebalances the board so each of three classes now has three directors.

  Item 5.02 verify on EDGAR →
• low

  The reclassification was done solely to comply with the company's certificate of incorporation requirements. Dr. Harr's service is deemed continuous with no interruption.

  8-K: Director Change verify on EDGAR →